Evaluating Strategies for Oral Absorption Enhancement
Formulation scientists tackle the challenges of improving drug absorption across the gastrointestinal membrane.

Helium Integrity Testing of Single-Use Vessels
Helium integrity testing can prevent failures in single-use bioprocessing vessels.

Advertisement: IMPORTFAB is a well-established contract manufacturer, specializing in the manufacturing and packaging of semi-solid and liquid products. Our objective is to maintain our position as a reliable reference point in the manufacturing of quality pharmaceutical products: essentially, a benchmark for modern, efficient production, assured through the use of highly performing equipment. IMPORTFAB is cGMP compliant by the FDA and Health Canada.www.importfab.com

Ruggedness of Visible Residue Limits for Cleaning-Part III: Visible Residue Limits for Different Materials of Construction
Risk of a cleaning failure due to visual failure for different materials of construction can be mitigated or eliminated using complementary cleaning validation studies.

Advertisement: Do More Together with Open Access Solutions Agilent’s open access solutions enable pharmaceutical scientists to accelerate discovery by simplifying the management of multiple LC/MS and NMR instruments. New MassHunter Walkup Software allows analytical chemists to easily configure and maintain multiple MS instruments, spending more time doing other work. New Vnmr J 4 Persona Manager provides NMR facility managers with a flexible platform for managing multiple users and spectrometers. Attend a webinarwww.agilent.com/chem/togetherpharma#openaccess

Genzyme to Expand Downstream Biologics Manufacturing Capacity
Genzyme will build a facility in Massachusetts to expand purification capacity for Fabrazyme (agalsidase beta).

AstraZeneca's MedImmune Acquires Spirogen and Strengthens Antibody-Drug Conjugate Capability
MedImmune expands its antibody-drug conjugate capability through acquisition and collaboration.

Advertisement: HANDS-ON TRAINING: Modern Tablet Manufacturing Learn the latest tablet technologies and how to improve your operations as leading academic and industry experts provide a well-balanced mix of classroom lectures and hands-on technical training. Learn More!

Abbott Reports Third-Quarter 2013 Results
Abbott’s third-quarter 2013 global sales increased slightly but were affected by a disruption in the International Nutrition business.

Advertisement: Longer lifespans and the growing prevalence of chronic illnesses pose a drug delivery challenge for health care providers, elderly patients and their caregivers. Patients with caregiver-intensive conditions often take multiple pills a day, and many suffer from difficulty swallowing. Transdermal drug delivery technology offers a patient-friendly solution, providing an innovative, efficient alternative to many oral medications.Find out how.

Johnson & Johnson Reports Third-Quarter 2013 Results
J&J announces 2013 third-quarter sales increased 3% over 2012 third-quarter sales.

Advertisement: Pharmaceutical Technology editorial staff proudly introduces PharmTech TV, their latest high quality pertinent content in a brand new industry-breaking format.Tune In Now

Kansas State University to Build Bulk Solids Innovation Center
Kansas State University to build Bulk Solids Innovation Center in Salina, Kansas.

Advertisement: Application of Engineering Solutions to Solve Challenges in Pharmaceutical Processing: Case Studies from Development to Production Scale On-Demand Webcast Register Free at www.pharmtech.com/solutions

FDA Awards 15 Grants to Stimulate Drug, Device Development for Rare Diseases
FDA has awarded 15 grants totaling more than $14 million to boost the development of products for patients with rare diseases.

FDA Takes Enforcement Action Against Dietary Supplement Manufacturer
FDA is seeking a permanent injunction against a dietary supplement manufacturer following the company’s repeated distribution of unapproved drugs and adulterated dietary supplements.

Advertisement: Implementing Risk Management for Regulatory Compliance Live Webcast: Tuesday, November 5, 2013 at 1:00 pm EDT Register Free at www.pharmtech.com/regcomp

Novozymes Biopharma To Collaborate with Almac
Novozymes Biopharma will collaborate with Almac to provide a combined service for drug development applications.

Aenova and Haupt Pharma To Merge
The Aenova Group will merge with Haupt Pharma, a company specializing in contract development and manufacturing.